Arteriovenous malformations market forecast to reach $4.37B by 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Arteriovenous Malformations Market Between 2026 And 2030?

The arteriovenous malformations market has experienced robust expansion in recent years. Its valuation is projected to rise from $3.1 billion in 2025 to $3.33 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.3%. Historically, this growth can be attributed to various elements such as enhancements in neuroimaging technologies, heightened clinical understanding of avm conditions, the establishment of more specialized neurosurgical centers, the implementation of endovascular embolization techniques, and the overall development of hospital-based neurological care.

The arteriovenous malformations market is poised for significant expansion in the coming years. Its value is projected to reach $4.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This anticipated growth during the forecast period is propelled by factors such as an escalating demand for precision diagnostics, increased investments in neurovascular research, the broadened adoption of minimally invasive treatments, a heightened focus on personalized treatment planning, and the growing availability of advanced interventional devices. Prominent trends observed within this period are expected to include the rising uptake of advanced neuroimaging diagnostics, an increased application of minimally invasive endovascular treatments, a stronger emphasis on early and accurate diagnosis, the expansion of multidisciplinary treatment approaches, and enhanced monitoring of post-treatment outcomes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/arteriovenous-malformations-global-market-report

What Major Factors Are Driving The Arteriovenous Malformations Market Forward?

The increasing preference for minimally invasive procedures is anticipated to fuel the expansion of the arteriovenous malformations market in the future. These interventions involve surgical or therapeutic methods using small incisions or catheter-based approaches to minimize trauma, shorten recovery periods, and reduce complications. The growing appeal of minimally invasive surgeries stems from their ability to offer quicker recovery times, as smaller incisions result in less tissue damage and faster healing. This enables patients to resume their regular routines more swiftly compared to conventional open surgeries, making them a favored option for both patients and healthcare providers. Arteriovenous malformations (AVMs) are compatible with minimally invasive techniques, facilitating advanced methods like endovascular embolization, which employs catheters and image guidance to diminish abnormal blood flow without the necessity for open surgery, thereby leading to reduced risks, shorter recovery, and enhanced patient results. For instance, data from September 2023, provided by the American Society of Plastic Surgeons, a US-based organization, indicated that 25,442,640 cosmetic minimally invasive procedures were carried out in 2023, marking an increase from 23,672,269 procedures in 2022. This demonstrates a 7% rise in minimally invasive treatments for both genders in 2023. Consequently, the escalating demand for minimally invasive procedures is propelling the growth of the arteriovenous malformations market.

Which Segment Classifications Are Used In The Arteriovenous Malformations Market Segment Analysis?

The arteriovenous malformations market covered in this report is segmented –

1) By Type: True Arteriovenous Malformation, Occult Or Cryptic, Cavernous Malformations, Venous Malformation, Hemangioma, Dural Fistula, Other Types

2) By Diagnosis: Physical examination, Brain Scans, Other Diagnosis

3) By Treatment: Endovascular Embolization, Neurosurgery

4) By Age Group: Adult Patients, Pediatric Patients

5) By End-User: Hospitals And Clinics, Research laboratories, Other End-Users

Subsegments:

1) By True Arteriovenous Malformation: Pial AVMs, Spinal AVMs, Brain AVMs, Extremity AVMs, Visceral AVMs

2) By Occult or Cryptic: Micro-AVMs, Hidden AVMs, Asymptomatic AVMs, Deep-Seated AVMs, Small-Scale AVMs

3) By Cavernous Malformations: Cerebral Cavernous Malformations (CCMs), Spinal Cavernous Malformations, Familial Cavernous Malformations, Solitary Cavernous Malformations, Multiple Cavernous Malformations

4) By Venous Malformation: Superficial Venous Malformations, Deep Venous Malformations, Mixed Venous Malformations, Syndromic Venous Malformations, Blue Rubber Bleb Nevus Syndrome

5) By Hemangioma: Infantile Hemangiomas, Capillary Hemangiomas, Lobular Capillary Hemangiomas, Cavernous Hemangiomas, Compound Hemangiomas

6) By Dural Fistula: Cranial Dural Arteriovenous Fistula (dAVF), Spinal Dural Arteriovenous Fistula, Direct Dural AV Fistula, Indirect Dural AV Fistula, High-Flow Dural Fistula

7) By Other Types: Lymphatic Malformations, Mixed Vascular Malformations, Arteriovenous Aneurysms, Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs, Rare Congenital AVMs

Which Trends Are Impacting The Progress Of The Arteriovenous Malformations Market?

Leading companies in the arteriovenous malformations market are concentrating on technological advancements, such as liquid embolic system procedural sets, to improve treatment efficiency and patient outcomes. A liquid embolic system procedural set refers to a pre-assembled, sterilized kit containing crucial components for delivering liquid embolic agents to address vascular abnormalities like arteriovenous malformations (AVMs). For instance, in March 2024, CERENOVUS Inc., a US-based neurovascular care company under Johnson and Johnson MedTech, introduced the TRUFILL n-BCA liquid embolic system procedural set. This new set comprises two configurations and the necessary accessories for preparing and delivering the n-BCA liquid embolic system in a single sterilized package, streamlining procedure preparation for treating cerebral arteriovenous malformations (AVMs).

Which Firms Are Contributing To The Arteriovenous Malformations Market Ecosystem?

Major companies operating in the arteriovenous malformations market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Terumo Corporation, Penumbra Inc, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc, Balt LLC, Shape Memory Medical Inc, MicroVention Inc, Cerenovus, Brainlab AG, Boston Scientific Corporation, Abbott Laboratories, B Braun Melsungen AG, Siemens Healthineers AG, GE Healthcare Technologies Inc, Koninklijke Philips NV, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation

Get The Full Arteriovenous Malformations Market Report:

https://www.thebusinessresearchcompany.com/report/arteriovenous-malformations-global-market-report

Which Region Is The Top Contributor To The Arteriovenous Malformations Market By Share?

North America was the largest region in the arteriovenous malformations market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriovenous malformations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Arteriovenous Malformations Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/arteriovenous-malformations-global-market-report

Browse Through More Reports Similar to the Global Arteriovenous Malformations Market 2026, By The Business Research Company

Vascular Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Vascular Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report

Giant Cell Arteritis Market Report 2026

https://www.thebusinessresearchcompany.com/report/giant-cell-arteritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795